| Literature DB >> 34080093 |
Geetanjali Saini1, Keerthi Gogineni2, Rick A Kittles3, Ritu Aneja4.
Abstract
Precision (or personalized) medicine holds great promise in the treatment of breast cancer. The success of personalized medicine is contingent upon inclusivity and representation for minority groups in clinical trials. In this article, we focus on the roadblocks for the African American demographic, including the barriers to access and enrollment in breast oncology trials, the prevailing classification of race and ethnicity, and the need to refine monolithic categorization by employing genetic ancestry mapping tools for a more accurate determination of race or ethnicity.Entities:
Keywords: African Americans; Ancestry informative markers; Oncology trials; Race/ethnicity classification
Mesh:
Year: 2021 PMID: 34080093 DOI: 10.1007/s10549-021-06264-x
Source DB: PubMed Journal: Breast Cancer Res Treat ISSN: 0167-6806 Impact factor: 4.872